A Study for HSK47388 in Participants With Ulcerative Colitis
Status:
NOT_YET_RECRUITING
Trial end date:
2029-02-02
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is to evaluate the efficacy and safety of HSK47388 as therapy in participants with moderately to severely active ulcerative colitis .